10 October 2016

Tackling antimicrobial resistance crisis - what roles will regulation and innovation play?

Organised by:

UK Members of the European Federation of Biotechnology (SCI, Biochemical Society, Microbiological Society, Society for Applied Microbiology and the Royal Society of Biology) in association with the Learned Society Partnership on AMR

Royal Society of Biology, London, UK

Registration Closed

This event is no longer available for registration.

Synopsis

This Policy Lates event will examine the roles of innovation and regulation in tackling the AMR crisis from different perspectives, including veterinary research, biotechnology and public health.

Earlier this year, a review of antimicrobial resistance (AMR) by Lord Jim O'Neill set out a comprehensive action plan for the world to prevent the spread of infectious diseases, develop new rapid diagnostic tools and incentivise research into new antibiotics.

According to the report, if not tackled urgently, antimicrobial resistance could kill 10 million people a year by 2050, the equivalent of 1 person every 3 seconds; more than cancer kills today.


Venue and Contact

Society of Biology

Charles Darwin House
12 Roger Street
London, WC1N 2JU

 

Gabriel Butkute

Tel:

Email: gabriele.butkute@rsb.org.uk


Fees

The event is FREE to attend.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Booking Process

Read our event booking terms and conditions


Partners

Additional Info

Speakers

  • Professor Jeff Cole, Vice President, European Federation of Biotechnology (Chair)
  • John Broughall, Antibiotic Research UK
  • Professor Mark Fielder, Kingston University
  • Tamar Ghosh, Lead, Longitude Prize, Nesta

For general enquiries, please call:

SCI

Emma Thomas
Committee Support Contact for the SCI Biotechnology Group
T: 0207 598 1594